Jan 19, 2021 (Financial News Media via COMTEX) -- FN Media Group Presents Safehaven.com Market Commentary
New York, NY - January 19, 2021 – One under-the-radar company looks to be an absolute game-changer for the healthcare industry. That's because, despite "Big Pharma's" massive resources and staggering amounts of spending, no large pharmaceutical company has ever been able to solve the industry's most critical problem. Mentioned in today's commentary includes: Tilray, Inc. /zigman2/quotes/209129655/composite TLRY -4.50% , Corbus Pharmaceuticals Holdings, Inc. /zigman2/quotes/201549545/composite CRBP -0.53% , Aurora Cannabis Inc. /zigman2/quotes/210559470/composite ACB -2.24% , Canopy Growth Corporation /zigman2/quotes/200603886/composite CGC +0.52% , Cronos Group Inc. /zigman2/quotes/206842762/composite CRON -1.66% .
That problem is a woefully inefficient drug development process. Drug development for major pharmaceutical companies can take as long as a decade…and cost hundreds of billions of dollars in research and development.
Yet a small, little-known company - which could become a truly disruptive cannabis player - now appears uniquely positioned to upend the drug development market by developing evidence-based cannabis products to combat many of the world's most serious medical conditions.
Juva Life (JUVA; JUVAF) is a California-based life science company - with roots in the cannabis industry, that is aiming at outsized profit potential by working to unlock the boundless therapeutic value of cannabis. By potentially solving the massive problem that Big Pharma doesn't like to admit, this small company offers the chance for true "market disruption" in this aspect of healthcare.
Research-Based Therapeutic Development Is Key
Before examining the high upside potential of Juva Life's natural product therapies, it's important to understand that the company's work in this area is built on a solid foundation of vertical integration. That's because Juva Life essentially consists of two businesses that support each other in a way that allows for significant potential upside.
The first business is the company's cannabis business - a vertically integrated cannabis operation located in northern California. Their cannabis business includes manufacturing, cultivation, distribution, and delivery capabilities, allowing it to take advantage of the massive California cannabis market. Here's what Juva Life's(JUVA; JUVAF) research is all about…
The current healthcare model is simply not working for millions of people. In order to develop a pharmaceutical-based drug - one that can be prescribed by a doctor - a company must be ready to invest up to 10 years of research and development along with potentially hundreds of millions of dollars.
Juva Life is building a novel technology platform founded on a more efficient clinical development pathway. This science-based approach offers a potentially game-changing alternative to what Big Pharma is currently offering the market. They are working to develop effective, targeted health solutions much more rapidly and at far less cost than Big Pharma is currently capable of.
Demand Is Growing
Juva Life (JUVA; JUVAF) is now working to meet that demand using a research-based approach. Rather than pursue FDA approvals that could take up to ten years, their therapeutics division is involved in medicinal cannabis-based product research that is designed to be far more efficient.
Using IRB-approved patient research registries and their collection of real-world data with patient-reported and clinical outcomes, their research division will work to develop a wide range of pharmacy-grade cannabis products. These products will each be rigorously tested, and meticulously formulated.
Perhaps best of all, this efficient clinical development pathway - with a laser-like focus on consumer needs - are aimed to help the company develop these products much more quickly than traditional drug development with far less risk and at significantly less cost.
If successful, Juva Life's research-based technology platform for drug development could be an absolute game-changer - but it offers even greater potential than simply offering products directly to consumers. The company's tech platform, as well as its ever-growing database of information on specific efficacies of medical cannabis - would then be likely to attract significant attention from "Big Pharma."
The reason is simple: One of Big Pharma's biggest problems is the mountains of money it costs and the time it takes to get new pharmaceutical drugs approved.
Juva Life's(JUVA; JUVAF) research protocols, already approved by the Western Institutional Review Board, could speed up the process dramatically. And the company is compiling massive amounts of data, including statistically relevant information about how specific products and cannabis strains demonstrate efficacy when treating specific ailments.
Maintain A Constant Revenue Stream
As a vertically integrated company, they pursue four revenue streams. In addition to their research, Juva Life's manufacturing, delivery, and retail revenue streams provide significant upside potential that helps fund the company's medical research efforts.
In terms of the cannabis revenue streams, they have…
Manufacturing - Juva Manufacturing will create Juva Life's in-house brands as well as white label products for other licensed recreational and medical cannabis companies.
Delivery - Juva Delivery is a network of cannabis delivery companies that service the San Francisco Bay Area and other cities within the state of California and currently generates at a run rate of $2.5 million in annual revenue for the company.
Retail - Juva Retail is a network of cannabis facilities that will serve the San Francisco Bay Area and other cities within the state of California. This includes a 1,000 square-foot dispensary in Hayward as well as having recently obtained an option on a high visibility retail location in downtown Redwood City.
Pioneers In The Cannabis Industry
From cultivation through manufacturing, quality control, testing and research, distribution, and retail customer experience, Juva Life(JUVA; JUVAF) brings together a best-in-class team. This team includes…
Doug Chloupek - Founder, CEO and Chairman
Doug has worked across a range of verticals and brought multiple new businesses to life. Valley Grown Enterprises, Lux Wellness, and Medmar Healing Center, to name a few, have created tangible value for both consumers and investors alike. His work co-founding BAS Research led to it being granted the first California license, issued by the City of Berkeley in 2016, for medical cannabis manufacturing and research.
Neil Ruditsky - Chief Operations Officer
Neil has spent more than two decades in senior leadership positions in the hospitality and cannabis industries. Under his leadership, Elemental Wellness grew from $4M to $20M in four years.